Flexible-Dose Trial in Early Parkinson's Disease (PD)

NCT04223193 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

304

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: Tavapadon
DRUG: Placebo

Sponsor

AbbVie